¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"Fracture of lower end of humerus"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 14 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
  • pathologic fracture
    º´Àû°ñÀý
  • perforating fracture
    °üÅë°ñÀý, ±¸¸Û°ñÀý
  • resecting fracture
    ÀýÁ¦°ñÀý, ±ðÀÓ°ñÀý
  • spiral fracture
    ³ª¼±Çü°ñÀý
  • spontaneous fracture
    ÀÚ¿¬°ñÀý
  • sprinter¡¯s fracture
    ´Ü°Å¸®ÁÖÀÚ°ñÀý
  • stellate fracture
    º°¸ð¾ç°ñÀý
  • stress fracture
    ±äÀå°ñÀý, ÇǷΰñÀý
  • senile fracture
    ³ë³â°ñÀý
  • shearing fracture
    ¾ù¹Ð¸²°ñÀý, Àü´Ü°ñÀý
  • silver fork fracture
    »ïÁöâ°ñÀý
  • simple fracture
    ´Ü¼ø°ñÀý, Æó¼â°ñÀý
  • tangential fracture
    Á¢¼±°ñÀý
  • ununited fracture
    ºñÀ¯ÇÕ°ñÀý
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
  • resecting fracture
    ÀýÁ¦°ñÀý, ±ïÀÓ°ñÀý
  • senile fracture
    ³ëÀΰñÀý
  • shearing fracture
    ºñƲ¸²°ñÀý, Àü´Ü°ñÀý
  • silver fork fracture
    »ïÁöâ°ñÀý
  • simple fracture
    (¢¡closed fracture) Æó¼â°ñÀý
  • spiral fracture
    ³ª¼±Çü°ñÀý
  • spontaneous fracture
    ÀÚ¿¬°ñÀý
  • sprinter¡¯s fracture
    ÁúÁÖÀÚ°ñÀý
  • stellate fracture
    º°°ñÀý, ¼º»ó°ñÀý
  • stress fracture
    ±äÀå°ñÀý, ÇǷΰñÀý
  • tangential fracture
    Á¢¼±°ñÀý
  • torsion fracture
    ºñƲ¸²°ñÀý, ¿°Àü°ñÀý
  • torus fracture
    ÆØÃ¢°ñÀý
  • transverse fracture
    °¡·Î°ñÀý, Ⱦ°ñÀý
  • triple fracture
    »ïÁß°ñÀý
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
  • lower center
    ÇÏÀ§ÁßÃß(ù»êÈñéõÒ).
  • lower central incisor
    ÇϾÇÁßÀýÄ¡(ù»äÉñé ôîöÍ).
  • lower cranial nerve nuclei
    ÇϺγú½Å°æÇÙ(ù»Ý»ÒàãêÌèú·).
  • lower cuspid
    ÇϾǰßÄ¡.
  • lower dental arch
    ÇÏÄ¡¿­±Ã(ù»öÍæêÏâ).
  • lower denture
    ÇϾÇÀÇÄ¡(ù»äÉëùöÍ).
  • lower differential coefficient
    ÇϹ̺аè¼ö(̰ËÑËÓË­Ëà).
  • lower esophageal ring
    ÇϺνĵµ·û(ù»Ý»ãÝÔ³ëÌ).
  • lower extremity
    ÇÏÁö(ù»ò¶).
  • lower eyelid
    ¾Æ·¡´«²¨Ç®, ÇϾȰË(ù»äÑÌ¡).
  • lower eyelid
    ¾Æ·¡´«²¨Ç®
  • lower facet ³ª fovea costalis inferior
    Çϸé(ù»Øü), ÇÏ´Á°ñ¿Í.
  • lower first bicuspid
    ÇϾÇÁ¦Àϼұ¸Ä¡(ù»äÉð¯ìéá³Ï¿öÍ).
  • lower first molar
    ÇϾÇÁ¦Àϴ뱸ġ(¡­ÓÞÏ¿öÍ).
  • lower incisor
    ÇϾÇÀýÄ¡(ù»äÉôîöÍ).
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 8
JCF juvenile calcaneal fracture
LBPF long bone or pelvic fracture
LFx linear fracture
NFS National Fertility Study; no fracture seen
SER sebum excretion rate; sensitizer enhancement ratio; sensory evoked response; service; smooth endopla...
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 8
TUNEL 5-triphosphate (dUTP)-biotin nick end-labeling
beta-END Beta-Endorphin
AGE Advanced Glycation End Products
AGE Advanced Glycosylated End-products
auto-PEEP Auto-positive end expiratory pressure
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • pathologic fracture
    º´Àû °ñÀý
  • periarticular fracture
    °üÀý ÁÖÀ§ °ñÀý
  • pyamidal fracture
    Ãßü °ñÀý
  • reduction of fracture
    °ñÀý Á¤º¹
  • silver fork fracture
    Æ÷¿ÀÅ© ¹è»ó °ñÀý, »ïÁöâ °ñÀý
  • simple fracture
    ´Ü¼ø °ñÀý
    1. ¿ÜºÎ¿Í ¿¬°áµÇÁö ¾ÊÀº ÇϳªÀÇ °ñÀý¼±À» °¡Áø´Ù. ÇϾÇÀÇ °æ¿ì °ñ¸·ÀÇ Âõ±èÀÌ ¾ø´Â ÇϾÇÁö °ñÀý, °úµÎ °ñÀý, ¶Ç´Â ¹«Ä¡¾Ç ºÎÀ§ÀÇ °ñÀý µîÀ» ÀǹÌÇÑ´Ù. 2. ¹Ù±ùÂÊÀ¸·Î ¿¬°áµÇÁö ¾ÊÀº ¼±»ó °ñÀý.
  • Skillern's fracture
    ½ºÅ³·± °ñÀý
    ¿ä°ñ ÇϺÎÀÇ ¿ÏÀü °ñÀý°ú ô°ñ ÇϺÎÀÇ ºÎÀü°ñÀÌ ÇÕº´ÇÑ °Í.
  • stress fracture
    ±äÀå °ñÀý, ÇÇ·Î °ñÀý
  • subcondylar fracture
    °úµÎÇÏ °ñÀý, °úµÎ ÇϺΠ°ñÀý
    °úµÎ ¹Ø°ú °úµÎ °æºÎ °ñÀý.
  • subperiosteal fracture
    °ñ¸·ÇÏ °ñÀý
    »ÀÀÇ À§Ä¡ º¯È­°¡ ¾øÀÌ °ñ¸· ¹Ø¿¡¼­ ÀϾ´Â °ñÀý.
  • subtrochanteric fracture
    ÀüÀÚÇÏ °ñÀý
  • supracondylar fracture
    °ú»ó °ñÀý
  • svulsion fracture
    °ß¿­ °ñÀý, ¹ßÃâ °ñÀý, ¹ßÃ⼺ °ñÀý
  • tooth fracture
    Ä¡¾Æ ÆÄÀý
  • transverse fracture
    Ⱦ°ñÀý
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 8
end plate potential <physiology> Depolarisation of the sarcolemma as a result of acetylcholine release from the motoneuron causing an influx of sodium ions. The endplate potential is the sum of quantal miniature endplate potentials. Development of the end plate potential is blocked by curare.
(18 Nov 1997)
end point <chemistry> It is the completion point during a titration reaction where there are equal amounts of titrant and whatever is being titrated. It is usually evident by the first perceptible alteration of the colour of an added indicator.
<immunology> It is the most dilute an antibody or antiserum solution can be while still detectably reacting with the antigen.
<statistics> A category of data used to compare the outcome in different arms of a clinical trial. Common endpoints are severe toxicity, disease progression or fall in such surrogate markers as CD4 count, but sometimes death is used as an endpoint.
(08 Mar 2000)
end-point measurement Analytical measurement at the end of a chemical reaction, as opposed to making the measurement while the reaction proceeds.
(05 Mar 2000)
end-point nystagmus A jerky, physiologic nystagmus occurring in a normal individual when attempts are made to fixate a point at the limits of the field of fixation.
Synonym: deviational nystagmus.
(05 Mar 2000)
end product <biochemistry> The final product of after a series of reactions with enzymes in a biochemical metabolic pathway has taken place.
(09 Oct 1997)
end product inhibition <biochemistry, physiology> The process of the end product of a particular metabolic reaction inhibiting an allosteric enzyme involved in that reaction as the reaction starts again, thus breaking the reaction cycle.
(09 Oct 1997)
end product repression Catabolite repression in which the catabolite is an end product of a particular pathway.
(05 Mar 2000)
end stage The late, fully developed phase of a disease; e.g., in end-stage renal disease, a shrunken and scarred kidney that may result from a variety of chronic diseases that have become indistinguishable in their effect on the kidney.
(05 Mar 2000)
end-stage renal disease <nephrology> A patient with inadequate renal function to support life. Individuals with end-stage disease must rely in kidney dialysis or peritoneal dialysis to survive. End-stage renal disease may be caused by a number of problems including diabetes, sickle cell disease, hypertension and congenital renal disease (polycystic kidney disease).
(27 Sep 1997)
end-systolic volume The amount of blood in the ventricle at the end of the cardiac ejection period and immediately preceding the beginning of ventricular relaxation; a measurement of the adequacy of cardiac emptying, related to systolic function.
(05 Mar 2000)
end-tidal at the end of a normal expiration.
(05 Mar 2000)
end-tidal sample A sample of the last gas expired in a normal expiration, ideally consisting only of alveolar gas.
(05 Mar 2000)
zero end-expiratory pressure Airway pressure which, at the end of expiration, equals atmospheric pressure.
(05 Mar 2000)
Krause's end bulbs Nerve terminals in skin, mouth, conjunctiva, and other parts, consisting of a laminated capsule of connective tissue enclosing the terminal, branched, convoluted ending of an afferent nerve fibre; generally believed to be sensitive to cold.
Synonym: corpuscula bulboidea, bulboid corpuscles.
(05 Mar 2000)
flush end <molecular biology> The ends of a blunt-end DNA molecule, where both strands in the double-stranded DNA molecule are even with each other rather than one strand being longer than the other.
(09 Oct 1997)
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 8
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 8
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 8
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 8
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 8
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 8
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 8
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 8
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 8
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 8
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 8
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 8
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 8
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 8
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 8
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 8
ÅëÇÕ°Ë»ö ¿Ï·á